Dr Croll reviews study linking tumor size changes on scans to pathological outcomes after neoadjuvant therapy in kidney cancer

Dr Benjamin Croll, MD, presented findings from a recent investigation into the relationship between radiographic size changes and pathological response in renal cell carcinoma patients receiving neoadjuvant therapy.

The study examined how reductions or increases in tumor dimensions measured by imaging correlated with the degree of tumor necrosis or residual disease observed after surgical removal.

Croll highlighted that understanding this correlation could help clinicians better predict treatment effectiveness and guide decision-making, though further validation is needed.